Children who are the youngest in their class to be identified with ADHD are just as likely to keep the diagnosis as older pupils in their year group, scientists have found.
Seelos’ stock plunges by over 75% after ketamine drug for suicide prevention fails a PhII trial
Seelos Therapeutics’ intranasal racemic ketamine candidate has missed the primary endpoint in a Phase II trial of major depressive disorder patients with acute suicidal ideation,
September 21, 2023